| Style | Citing Format |
|---|---|
| MLA | Ali Rana A, et al.. "Clinical Outcomes of Low Versus High Intensity Laser Therapy in Patients With Subacute Carpal Tunnel Syndrome: A Randomized, Single-Blinded, Controlled Trial." Lasers in Medical Science, vol. 41, no. 1, 2026, pp. -. |
| APA | Ali Rana A, Ahmad A, Bashardoust Tajali S, Munawar A, Shabbir M (2026). Clinical Outcomes of Low Versus High Intensity Laser Therapy in Patients With Subacute Carpal Tunnel Syndrome: A Randomized, Single-Blinded, Controlled Trial. Lasers in Medical Science, 41(1), -. |
| Chicago | Ali Rana A, Ahmad A, Bashardoust Tajali S, Munawar A, Shabbir M. "Clinical Outcomes of Low Versus High Intensity Laser Therapy in Patients With Subacute Carpal Tunnel Syndrome: A Randomized, Single-Blinded, Controlled Trial." Lasers in Medical Science 41, no. 1 (2026): -. |
| Harvard | Ali Rana A et al. (2026) 'Clinical Outcomes of Low Versus High Intensity Laser Therapy in Patients With Subacute Carpal Tunnel Syndrome: A Randomized, Single-Blinded, Controlled Trial', Lasers in Medical Science, 41(1), pp. -. |
| Vancouver | Ali Rana A, Ahmad A, Bashardoust Tajali S, Munawar A, Shabbir M. Clinical Outcomes of Low Versus High Intensity Laser Therapy in Patients With Subacute Carpal Tunnel Syndrome: A Randomized, Single-Blinded, Controlled Trial. Lasers in Medical Science. 2026;41(1):-. |
| BibTex | @article{ author = {Ali Rana A and Ahmad A and Bashardoust Tajali S and Munawar A and Shabbir M}, title = {Clinical Outcomes of Low Versus High Intensity Laser Therapy in Patients With Subacute Carpal Tunnel Syndrome: A Randomized, Single-Blinded, Controlled Trial}, journal = {Lasers in Medical Science}, volume = {41}, number = {1}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Ali Rana A AU - Ahmad A AU - Bashardoust Tajali S AU - Munawar A AU - Shabbir M TI - Clinical Outcomes of Low Versus High Intensity Laser Therapy in Patients With Subacute Carpal Tunnel Syndrome: A Randomized, Single-Blinded, Controlled Trial JO - Lasers in Medical Science VL - 41 IS - 1 SP - EP - PY - 2026 ER - |